title: A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.
abstract: Aberrant activation of the Wingless-type (Wnt)/beta-catenin signaling pathway is associated with a variety of human cancers. Little is known regarding the role that Wnt ligands play in human carcinogenesis. To test whether a Wnt-1 signal is a survival factor in human cancer cells and thus may serve as a potential cancer therapeutic target, we investigated the effect of inhibition of Wnt-1 signaling in a variety of human cancer cell lines, including non small cell lung cancer, breast cancer, mesothelioma, and sarcoma. Both monoclonal antibody and RNA interference (RNAi) were used to inhibit Wnt-1 signaling. We found that incubation of a monoclonal anti-Wnt-1 antibody induced apoptosis and caused downstream protein changes in cancer cells overexpressing Wnt-1. In contrast, apoptosis was not detected in cells lacking or having minimal Wnt-1 expression after the antibody incubation. RNAi targeting of Wnt-1 in cancer cells overexpressing Wnt-1 demonstrated similar downstream protein changes and induction of apoptosis. The antibody also suppressed tumor growth in vivo. Our results indicate that both monoclonal anti-Wnt-1 antibody and Wnt-1 siRNA inhibit Wnt-1 signaling and can induce apoptosis in human cancer cells. These findings hold promise as a novel therapeutic strategy for cancer.
authors.affiliation: Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.
authors.forename: Biao
authors.initials: B
authors.lastname: He
authors.forename: Liang
authors.initials: L
authors.lastname: You
authors.forename: Kazutsugu
authors.initials: K
authors.lastname: Uematsu
authors.forename: Zhidong
authors.initials: Z
authors.lastname: Xu
authors.forename: Amie Y
authors.initials: AY
authors.lastname: Lee
authors.forename: Maria
authors.initials: M
authors.lastname: Matsangou
authors.forename: Frank
authors.initials: F
authors.lastname: McCormick
authors.forename: David M
authors.initials: DM
authors.lastname: Jablons
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D015153:Blotting, Western; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D006801:Humans; D020287:In Situ Nick-End Labeling; D020411:Oligonucleotide Array Sequence Analysis; D011233:Precipitin Tests; D011518:Proto-Oncogene Proteins / Q000276:immunology / Q000378:metabolism*; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D051153:Wnt Proteins; D051155:Wnt1 Protein
chemical_list: D000911:Antibodies, Monoclonal; D011518:Proto-Oncogene Proteins; C495247:WNT1 protein, human; D051153:Wnt Proteins; D051155:Wnt1 Protein